SlidesetHIVINTEREST 2016(Abstract) Pre-Clinical Evaluation of optimized Immunogens targeting the neutralizing epitopes in MPER of HIV envelope GlycoproteinView Slideset
SlidesetHIVINTEREST 2016(Abstract) Operational research studies among MSM in Cameroon: Linkage to treatment challenges | U. TamoufeView Slideset
SlidesetHIVINTEREST 2016Men who have sex with men in sub-Saharan Africa | Iliassou Mfochive Njindam, MD, MPHView Slideset
SlidesetHIVINTEREST 2016(Abstract) Finding the first 90% to achieve epidemic control | J. MasedzaView Slideset
SlidesetHIVINTEREST 2016Drug Use in sub-Saharan Africa: opportunities and challenges | Reychad Abdool, MDView Slideset
SlidesetHIVINTEREST 2016Prevention Tools: Implementation and Discovery | Cissy Kityo, MDView Slideset
SlidesetHIVINTEREST 2016Update on HIV vaccine strategies and trials: Active and passive immunization strategies | Hannah Kibuuka, MDView Slideset
SlidesetHIVINTEREST 2016(Abstract) Accumulation of HIV-1 drug resistance after continued virological failure on first-line antiretroviral therapy in adults and children | T.S.BoenderView Slideset
SlidesetHIVINTEREST 2016(Abstract) Tenofovir-containing first-line ART favourably reduce inflammation markers compared to thymidine analogue nucleoside reverse-transcriptase inhibitors | S. KroezeView Slideset
SlidesetHIVINTEREST 2016(Abstract) EDCTP as a model for Europe-Africa partnership on HIV/AIDS research and capacity development: Examples from Cameroon | L.J. PandyaView Slideset
SlidesetHIVINTEREST 2016Trial, post-trial, & demonstration project results for Pre-exposure Prophylaxis (PrEP) | Elizabeth Irungu, MBChB, MPHView Slideset
